Table 1.
TotalNo. ofc |
No. with Diagnosisd |
|||||||||||||||||
Study Site | First Authora | DiagnosticCriteriab | Peds | Aff | Model1 | Model2 | Model3 | BP-I | SAB | BP-II | RUP | Other | No. of Markers | No. ofEmptyBinse | GeneticModel(s)f | Type of Analysis | OutputUsedg | Ethnicityh |
Very narrow analysis: | ||||||||||||||||||
NIMH | Detera-Wadleigh1 | R+D3R | 97 | 424 | 264 | 336 | 424 | 232 | 32 | 72 | 88 | 355 | 3 | NP | Multipoint | NPL | NAm | |
U.K./Irish | Bennett2 | D4 | 151 | 367 | 288 | 325 | 367 | 288 | 12 | 25 | 34 | 8 | 398 | 0 | NP | Multipoint | MLS | Ir+Br |
Columbia | Liu3 | R | 39 | 297 | 115 | 208 | 297 | 101 | 14 | 93 | 89 | 333 | 0 | D+R | Two-point | LOD | NAm | |
Finland) | Ekholm4 | D4 | 41 | 132 | 107 | 107 | 132 | 95 | 12 | 2 | 16 | 7 | 368 | 0 | D+R | Two-point | LOD | Finnish |
Sydney 1 | Badenhop5 | R | 13 | 69 | 40 | 44 | 69 | 33 | 7 | 4 | 25 | 298 | 0 | (4) | Two-point | LOD | Eur (Aust) | |
Sydney 2 | Schofield6 | R | 15 | 63 | 41 | 46 | 63 | 31 | 10 | 5 | 17 | 382 | 0 | (4) | Two-point | LOD | Eur (Aust) | |
Quebec | Morissette7 | D3R | 5 | 56 | 42 | 42 | 56 | 39 | 3 | 5 | 9 | 314 | 0 | D+R | Two-point | LOD | Quebec isol | |
Edinburgh | Blackwood8 | D3R | 7 | 41 | 27 | 36 | 41 | 27 | 8 | 1 | 5 | 372 | 0 | D+R | Two-point | LOD | British | |
Costa Rica | McInnis9 | D3R | 2 | 24 | 24 |
24 | 24 | 22 |
2 |
473 | 1 | D | Two-point | LOD | CR isol | |||
Total (Model 1) | 948 | 868 | 80 | |||||||||||||||
Added for narrow analysis: | ||||||||||||||||||
Hopkins/Dana | McInnis10 | R | 65 | 301 | 232 | 301 | 129 | 6 | 97 | 69 | 823 | 0 | NP | Multipoint | NPL | NAm | ||
Bonn | Cichon11,i | R+D3R | 75 | 245 | 128 | 128 | 104 | 24 | (23) | 359 | 0 | NP | Multipoint | NPL | G+Is+It | |||
NIMH-IM | Detera-Wadleigh12 | R | 22 | 160 | 118 | 160 | 64 | 18 | 36 | 42 | 584 | 0 | NP | Multipoint | MLS | NAm+OOA | ||
UCSD | Kelsoe13 | D3R | 20 | 76 | 48 | 76 | 33 | 15 | 28 | 428 | 1 | (3) | Two-point | LOD | NAm | |||
UC London | Curtis14,j | R | 7 | 74 | 39 |
39 | 24 |
15 |
(35) | 365 | 0 | Max | Two-point/three-point | LOD | Br+Icelandic | |||
Total (models 1+2) | 1,733 | 1,222 | 124 | 394 | ||||||||||||||
Added for broad analysis: | ||||||||||||||||||
Ottawa | Turecki15 | R | 31 | 106 | 106 | 33 | 3 | 25 | 45 | 363 | 1 | (5) | Two-point | LOD | Eur (Can) | |||
Antwerp 1 | Van Broeckhoven16 | R | 10 | 56 | 56 | 14 | 1 | 15 | 21 | 5 | 372 | 0 | D+R | Two-point | LOD | Belgian | ||
Utah | Coon17 | R | 8 | 51 | 51 | 20 | 12 | 19 | 328 | 19 | D | Two-point | LOD | Eur | ||||
Antwerp 2 | Van Broeckhoven16 | R | 9 | 47 | 47 |
22 |
2 |
6 |
17 |
361 | 0 | NP | Multipoint | NPL | Swedish | |||
Total (models 1+2+3) | 2,437 | 1,311 | 130 | 452 | 524 | 20 |
Note.— Total number of pedigrees collected is shown here; the numbers included in the model 1 and 2 analyses are shown in figures 1 and 2.
Superscripts indicate references as follows: 1 = Detera-Wadleigh et al. (1997), Edenberg et al. (1997), Rice et al. (1997), and Stine et al. (1997); 2 = Bennett et al. (2002); 3 = Liu et al. (2003); 4 = Ekholm et al. (2002) and J.E., L.P., and J.Lö. (unpublished data); 5 = Badenhop et al. (2002); 6 = R.F.B., P.B.M., J.A.D., L.J.A., and P.R.S. (unpublished data) and Badenhop et al. (2002); 7 = Morissette et al. (1999); 8 = Blackwood et al. (1996) and D. Blackwood, W. Muir, D. Porteus, and S. Macgregor (unpublished data); 9 = McInnis et al. (1996); 10 = McInnis et al. (2003); 11 = Cichon et al. (2001); 12 = Detera-Wadleigh et al. (1999); 13 = Kelsoe et al. (2001); 14 = Curtis et al. (2003); 15 = Turecki et al. (2001); 16 = C.V., S.Cl., J.M., and R.A. (unpublished data); 17 = Coon et al. (1993).
R = RDC; D3R = DSM-IIIR; D4 = DSM-IV.
Peds = informative pedigrees; Aff = affected genotyped cases.
SAB = schizoaffective bipolar; RUP = recurrent major depressive (unipolar) disorder; Other = other mood disorder. Columns for Models 1 (BP-I+SAB), 2 (+BP-II) and 3 (+RUP) show the number of genotyped affected cases; additional columns show numbers for each diagnosis. Data from narrower models were carried over if the broader model was not available. For Bennett and Blackwood, SAB cases (highlighted in boldface italic type) were included in model 2 but not model 1 analyses. For Cichon, BP–not otherwise specified cases were judged equivalent to DSM-IV BP-II by the investigators and are listed as such here. “Other” diagnoses were distributed and handled as follows (included in model 3 analyses, because these cases were a small proportion of the study’s broadest analysis): from Bennett, eight BP–not otherwise specified; from Ekholm, three BP–not otherwise specified, two single-episode unipolar, and two cyclothymia; from Van Broeckhoven (Antwerp 1), five cyclothymia. Excluded from model 1 (included in model 4): from Cichon, 23 single-episode unipolar; from Curtis, 28 single-episode unipolar and RUP, and seven other mood disorders.
Number of bins with 0 markers.
NP = nonparametric, no model; D = dominant; R = recessive; max = maximized over parameters. Numbers in parentheses indicate the number of models tested.
LOD = parametric LOD score; MLS = maximum LOD score, ASP analysis.
Br = British; Eur = predominantly European descent; Ir = Irish; It = Italian; NAm= North American (predominantly European); Aust = Australian; CR = Costa Rican; G = German; Is = Israeli; Can = Canadian; OOA= Old Order Amish isolate; isol = genetic isolate.
For Cichon, included in models 2 and 3 was an analysis of 104 BP-I and 24 BP-II cases; the only other analysis included 128 BP-I, 14 SAB, 40 BP-II, 40 RUP, and 23 Other cases and was used here only for model 4.
For Curtis, an analysis of 24 BP-I and 15 BP-II cases was included in models 2 and 3; an additional 35 Other cases were included only in model 4.